Skip to main content
IDXX logo

IDXX · Idexx Laboratories Inc · Documents

Track IDXX — free
Market Cap
$55.20B
Shares
78.79M
Volume · Nov 16 491.5K Avg daily vol (3M) 567.85K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Aug 6
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $1B ▲ 6.4% Net income $203.3M ▼ 9.3% Diluted EPS $2.44 ▼ 8.6%
May 1
Quarterly report 10-Q FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $964.1M ▲ 7.1% Net income $235.58M ▲ 10.1% Diluted EPS $2.81 ▲ 10.2%
Feb 22
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $3.66B ▲ 8.7% Net income $845.04M ▲ 24.4% Diluted EPS $10.06 ▲ 25.3%
2023
Nov 1
Quarterly report 10-Q FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $915.53M ▲ 8.8% Net income $212.23M ▲ 17.3% Diluted EPS $2.53 ▲ 17.7%
Aug 1
Quarterly report 10-Q FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $943.63M ▲ 9.7% Net income $224.24M ▲ 69.9% Diluted EPS $2.67 ▲ 71.2%
May 2
Quarterly report 10-Q FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $900.2M ▲ 7.6% Net income $214.05M ▲ 10.4% Diluted EPS $2.55 ▲ 12.3%
Feb 16
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $3.37B ▲ 4.7% Net income $679.09M ▼ 8.8% Diluted EPS $8.03 ▼ 6.6%
2022
Nov 1
Quarterly report 10-Q FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $841.66M ▲ 3.9% Net income $180.94M ▲ 3.3% Diluted EPS $2.15 ▲ 5.9%
Aug 2
Quarterly report 10-Q FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $860.55M ▲ 4.2% Net income $131.98M ▼ 34.9% Diluted EPS $1.56 ▼ 33.3%
May 4
Quarterly report 10-Q FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $836.55M ▲ 7.6% Net income $193.97M ▼ 5.0% Diluted EPS $2.27 ▼ 3.4%
Feb 16
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $3.22B ▲ 18.8% Net income $744.85M ▲ 28.0% Diluted EPS $8.60 ▲ 28.2%
Showing 51–100 of 135 documents
Key facts CIK 874716 CUSIP 45168D104 13F (30d) 1100 filings 1044 filers Visit website Investor relations